Patent Assignment
Reel/Frame 054617/0820
Assignment of Assignor's Interest
Recorded: 2020-12-11
Pages: 5
Assignor
BACHMANN, MICHAEL
Executed: 2020-12-03
Assignee
GEMOAB MONOCLONALS GMBH
TATZBERG 47, DRESDEN, 01307, GERMANY
Covered Property
(1)
Reversed Universal Chimeric Antigen Receptor Expressing Immune Cells for Targeting of Diverse Multiple Antigens and Method of Manufacturing the Same and Use of the Same for Treatment of Cancer, Infections and Autoimmune Disorders
Application:
17/251,447 →
Publication:
US 2021/0309751
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Nov 23, 2021
From: GEMOAB MONOCLONALS GMBH
To: GEMOAB GMBH
Reel/Frame 058566/0170 →
Change of Name
Mar 17, 2022
From: GEMOAB GMBH
To: AVENCELL EUROPE GMBH
Reel/Frame 059390/0606 →
Security Interest
Jan 4, 2024
From: AVENCELL THERAPEUTICS, INC.
To: BXLS V - DIAMANT L.P., AS COLLATERAL AGENT
Reel/Frame 066026/0610 →
Release of Security Interest
Oct 18, 2024
From: BXLS V – DIAMANT L.P.
To: AVENCELL THERAPEUTICS, INC.
Reel/Frame 068941/0187 →